Skip to main content
Midas Edge

Bioceres Crop Solutions Corp.

For the period ended May 12, 2026. Filed May 12, 2026.

View on SEC.gov

About this filing

What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.

May 12, 2026 · Filed May 12, 2026

Use the contents to explore the available documents and sections.

BIOX$0.23+10.2%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

EX-99.1 · Table 7:

Table 7:

3Q26 Adjusted EBITDA 1 Reconciliation from Profit/(Loss) for the period

(In millions of U.S. dollars)As of March, 31
20252026
Profit/(loss) for the period2.3(10.0)
Income tax(3.6)(4.0)
Financial results5.69.7
Depreciations & amortizations3.83.4
Stock-based compensation charges0.90.1
Transaction expenses-0.3
Adjusted EBITDA19.1(0.6)
10BIOCERES CROP SOLUTIONSTHIRD QUARTER 2026

**Unaudited Consolidated Statement of Comprehensive Income

**(Figures in million of U.S. dollars)

Continuing operationsThree-month period ended 03/31/2026Three-month period ended 03/31/2025
Revenues from contracts with customers38.250.1
Initial recognition and changes in the fair value of biological assets at the point of harvest1.21.0
Cost of sales(26.7)(33.0)
Gross profit12.718.1
% Gross profit32%35%
Operating expenses(18.0)(21.3)
Share of profit of JV0.5(0.9)
Change in net realizable value of agricultural products(0.2)(0.2)
Other income or expenses, net0.78.8
Operating profit(4.3)4.3
Financial result(9.7)(5.6)
Profit/(loss) before income tax(14.1)(1.2)
Income tax4.03.6
Profit/(loss) for the period from continuing operations(10.0)2.3
Discontinued operations
Loss for the period from discontinued operations-(3.9)
Loss for the period from discontinued operations-(3.9)
Other comprehensive profit/loss0.3(0.8)
Total comprehensive profit/(loss)(9.7)(2.4)
Profit/(loss) for the period of continuing operations attributable to
Equity holders of the parent(9.0)2.6
Non-controlling interests(1.1)(0.3)
(10.0)2.3
Weighted average number of shares
Basic63.662.8
Diluted63.662.8
11BIOCERES CROP SOLUTIONSTHIRD QUARTER 2026

Unaudited Consolidated Statement of Financial Position

(Figures in million of U.S. dollars)

ASSETS31/03/202630/06/2025
CURRENT ASSETS
Cash and cash equivalents14.432.7
Other financial assets0.52.0
Trade receivables136.3165.9
Other receivables13.015.9
Recoverable income tax1.41.9
Inventories48.487.6
Biological assets4.42.4
Assets subject to foreclosure42.4-
Total current assets260.7308.3
NON-CURRENT ASSETS
Other financial assets0.00.0
Trade receivables4.82.5
Other receivables25.723.7
Recoverable income tax0.00.0
Deferred tax assets6.54.9
Investments in joint ventures and associates40.639.4
Investment properties-0.6
Property, plant and equipment60.074.6
Intangible assets83.9181.2
Goodwill36.1112.2
Right of use asset11.416.4
Total non-current assets268.9455.3
Total assets529.6763.6
LIABILITIES31/03/202630/06/2025
CURRENT LIABILITIES
Trade and other payables79.696.4
Borrowings66.4119.7
Employee benefits and social security3.66.2
Deferred revenue and advances from customers2.84.3
Income tax payable4.80.5
Consideration for acquisition2.11.8
Secured notes108.3102.3
Lease liabilities2.66.9
Liabilities subject to foreclosure27.4-
Total current liabilities297.5338.0
NON-CURRENT LIABILITIES
Trade and other payables46.248.5
Borrowings54.138.2
Deferred revenue and advances from customers1.41.4
Joint ventures and associates0.71.0
Deferred tax liabilities24.330.1
Provisions1.01.3
Consideration for acquisition0.00.4
Secured notes--
Lease liabilities8.69.5
Total non-current liabilities136.4130.4
Total liabilities433.9468.4
EQUITY
Equity attributable to owners of the parent67.7265.4
Non-controlling interest27.929.8
Total equity95.7295.2
Total equity and liabilities529.6763.6
12BIOCERES CROP SOLUTIONSTHIRD QUARTER 2026
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.